MassMutual Private Wealth & Trust’s Editas Medicine EDIT Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.72K	Hold	530	–	–	﹤0.01%	2046
2026 Q1	$1.31K	Hold	530	–	–	﹤0.01%	2078
2025 Q4	$1.09K	Buy	+530	New	+$1.53K	﹤0.01%	2128
2025 Q1	–	Sell	-120	Closed	-$152	–	2385
2024 Q4	$152	Buy	+120	New	+$306	﹤0.01%	2266
2023 Q2	–	Sell	-100	Closed	-$725	–	1934
2023 Q1	$725	Buy	+100	New	+$889	﹤0.01%	1618
2022 Q2	–	Sell	-459	Closed	-$9K	–	1567
2022 Q1	$9K	Hold	459	–	–	﹤0.01%	760
2021 Q4	$12K	Hold	459	–	–	﹤0.01%	694
2021 Q3	$19K	Sell	459 -1	-0.2%	-$55	﹤0.01%	608
2021 Q2	$26K	Sell	460 -310	-40%	-$11.5K	﹤0.01%	542
2021 Q1	$32K	Buy	770 +141	+22%	+$8.03K	﹤0.01%	475
2020 Q4	$44K	Buy	629 +253	+67%	+$10.4K	﹤0.01%	455
2020 Q3	$11K	Sell	376 -42	-10%	-$1.37K	﹤0.01%	563
2020 Q2	$12K	Hold	418	–	–	﹤0.01%	530
2020 Q1	$8K	Hold	418	–	–	﹤0.01%	536
2019 Q4	$12K	Buy	+418	New	+$10.4K	﹤0.01%	593

Other funds holding EDIT

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

MassMutual Private Wealth & Trust's EDIT Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Editas Medicine (EDIT) position steady in Q2 2026 at 530 shares worth $1.72K. The position accounts for ﹤0.01% of the portfolio, ranked #2046.

MassMutual Private Wealth & Trust first reported a position in EDIT in Q4 2019 and has held it in 15 quarters since. The position peaked at $44K in Q4 2020. 215 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

MassMutual Private Wealth & Trust held 530 shares of Editas Medicine worth $1.72K as of Q2 2026.
MassMutual Private Wealth & Trust left its Editas Medicine share count unchanged in Q2 2026.
Editas Medicine made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #2046 holding.
MassMutual Private Wealth & Trust first reported a position in Editas Medicine in Q4 2019 and has held it in 15 quarters since.
MassMutual Private Wealth & Trust's Editas Medicine position peaked at $44K in Q4 2020.
215 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.